Annual Meeting Archives
2010
Institutions:
Department of Pharmaceutics, School of Pharmacy, The University of Mississippi, University, MS-38677, USA. National Center for Natural Products Research, The University of Mississippi, University, MS-38677, USA. 3BASF SE, R&D Project Management Excipients, Ludwigshafen-67056, Germany. National Center for Natural Products Research, The University of Mississippi, University, MS-38677, USA. 4BASF Corporation, US HWY 46 W, Ledgewood, NJ-07852, USA. marepka@olemiss.edu
Institutions:
Department of Pharmaceutics and Pharmaceutical Chemistry, Center for Nanomedicine, Nano Institute of Utah, Department of Bioengineering, University of Utah, Salt Lake City, UT, 84108, USA, robert.a.price@utah.edu
Institutions:
Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai, 201203, P.R. China wylu@shmu.edu.cn
Institutions:
Medicines Research Unit, Aston University, Birmingham, B4 7ET, UK, y.perrie@aston.ac.uk
Institutions:
School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA 30332 prausnitz@gatech.edu
Institutions:
Departments of Pharmaceutics and Biomedical Engineering, University of Minnesota, Minneapolis, MN 55455, USA, siege017@umn.edu
Institutions:
Alnylam Pharmaceuticals, Cambridge, MA, 02142, USA; Tekmira Pharmaceuticals, Burnaby, BC, V5J 5J8, Canada; AlCana Technologies, Vancouver, BC, V6T 1Z4, Canada; Max Planck Institute, Dresden, 01309, Germany; Massachusetts Institute of Technology, Cambridge, MA, 02139, USA
Institutions:
Department of Bioengineering, University of Maryland, College Park, MD 20742, USA; Center for Nanomedicine & Cellular Delivery & Department of Pharmaceutical Sciences, University of Maryland, Baltimore, MD 21201, USA; Departments of Pharmaceutics and Pharmaceutical Chemistry & Bioengineering, Center for Nanomedicine, Nano Institute of Utah, University of Utah, Salt Lake City, UT 84108, USA
Institutions:
Faculty of Engineering, Kyushu University, Fukuoka 819-0395, Japan; Center for Future Chemistry, Kyushu University, Fukuoka 819-0395, Japan; PRESTO, Japan Science and Technology Agency, Kawagushi 332-0012, Japan
niidome.takuro.655@m.kyushu-u.ac.jp
niidome.takuro.655@m.kyushu-u.ac.jp
Institutions:
Bio-Images Research Ltd, Glasgow, G4 0SF, UK; Strathclyde Institute of Pharmacy and Biomedical Sciences, Glasgow, G4 0NR, UK; h.n.e.stevens@strath.ac.uk
Institutions:
Georgia Institute of Technology, Atlanta Georgia. USA
Institutions:
Microbicide Research Branch (MRB), Prevention Sciences Program (PSP), Division of AIDS (DAIDS), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services (HHS), 6700-B Rockledge Drive, Room 5118, Bethesda, MD 20892, USA, jturpin@niaid.nih.gov
Institutions:
University of Nottingham, Nottingham, NG7 2RD, UK; 2 RegenTec Ltd, Nottingham, NG1 1GF, UK, kevin.shakesheff@nottingham.ac.uk
2009
Institutions:
SINTEF Materials and Chemistry, N-7465 Trondheim, Norway; Resman AS, N-7041 Trondheim, Norway, NetKem AS, N-1410 Kolbotn, Norway, ruth.b.schmid@sintef.no
Institutions:
Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, 3584 CA, Utrecht, The Netherlands, i.vanrooy@uu.nl
Institutions:
Kyoto Pharmaceutical University, Yamashina-ku, Kyoto 607-8414, Japan Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan hkatsumi@mb.kyoto-phu.ac.jp
Institutions:
Shaare Zedek Medical Center and Hebrew University-School of Medicine, Jerusalem, 91031, Israel albertog@ekmd.huji.ac.il
Institutions:
School of Engineering and Material Sciences, Queen Mary University of London, E1 4NS, London, UK; MPI of Colloids and Interfaces, Potsdam, 14424, Germany; Center for Nanoscience, LM University, Munich, Germany; Department of Pharmaceutics, Ghent University, 9000 Ghent, Belgium; Department of Physics, Philipps University Marburg, Marburg, Germany, g.sukhorukov@qmul.ac.uk
Institutions:
Bayer Technology Services GmbH, Bldg. E41, 51368 Leverkusen, GERMANY, jens.uhlemann@bayertechnology.com
Institutions:
Department of Bioengineering, Hanyang University, 17, Haengdang-dong, Seongdong-gu, Seoul, 133-791, Republic of Korea,, darkne@hanyang.ac.kr
Release Mechanisms of Antiproliferative Drugs from Novel Highly Porous Bioresorbable Stent Coatings.
Institutions:
Department of Biomedical, Tel -Aviv University, Tel-Aviv, 69978, Israel, Department of Neurobiology, Tel -Aviv University, Tel-Aviv, 69978, Israel, amirkrai@tau.ac.il